BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 28669864)

  • 21. Factors associated with Clostridium difficile infection: A nested case-control study in a three year prospective cohort.
    Khanafer N; Vanhems P; Barbut F; Luxemburger C; ; Demont C; Hulin M; Dauwalder O; Vandenesch F; ; Argaud L; Badet L; Barth X; Bertrand M; Burillon C; Chapurlat R; Chuzeville M; Comte B; Disant F; Fessy MH; Gouillat C; Juillard L; Lermusiaux P; Monneuse O; Morelon E; Ninet J; Ponchon T; Poulet E; Rimmele T; Tazarourte K
    Anaerobe; 2017 Apr; 44():117-123. PubMed ID: 28279859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of inflammatory bowel disease with
    D'Aoust J; Battat R; Bessissow T
    World J Gastroenterol; 2017 Jul; 23(27):4986-5003. PubMed ID: 28785153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort Study.
    Ianiro G; Murri R; Sciumè GD; Impagnatiello M; Masucci L; Ford AC; Law GR; Tilg H; Sanguinetti M; Cauda R; Gasbarrini A; Fantoni M; Cammarota G
    Ann Intern Med; 2019 Nov; 171(10):695-702. PubMed ID: 31683278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe.
    Kurti Z; Lovasz BD; Mandel MD; Csima Z; Golovics PA; Csako BD; Mohas A; Gönczi L; Gecse KB; Kiss LS; Szathmari M; Lakatos PL
    World J Gastroenterol; 2015 Jun; 21(21):6728-35. PubMed ID: 26074711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hospitalized Patients with Heart Failure and Common Bacterial Infections: A Nationwide Analysis of Concomitant Clostridium Difficile Infection Rates and In-Hospital Mortality.
    Mamic P; Heidenreich PA; Hedlin H; Tennakoon L; Staudenmayer KL
    J Card Fail; 2016 Nov; 22(11):891-900. PubMed ID: 27317844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors and outcome of PCR-detected Clostridium difficile infection in ileal pouch patients.
    Li Y; Qian J; Queener E; Shen B
    Inflamm Bowel Dis; 2013 Feb; 19(2):397-403. PubMed ID: 23328770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clostridium difficile infection among hospitalized HIV-infected individuals: epidemiology and risk factors: results from a case-control study (2002-2013).
    Di Bella S; Friedrich AW; García-Almodóvar E; Gallone MS; Taglietti F; Topino S; Galati V; Johnson E; D'Arezzo S; Petrosillo N
    BMC Infect Dis; 2015 Apr; 15():194. PubMed ID: 25899507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection, treatment, and prevention of Clostridium difficile infection.
    McCollum DL; Rodriguez JM
    Clin Gastroenterol Hepatol; 2012 Jun; 10(6):581-92. PubMed ID: 22433924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the risk and disease burden of Clostridium difficile infection among patients with hospital-acquired pneumonia at a University Hospital in Central China.
    Li C; Duan J; Liu S; Meng X; Fu C; Zeng C; Wu A
    Infection; 2017 Oct; 45(5):621-628. PubMed ID: 28497295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of real-time notification of Clostridium difficile test results and early initiation of effective antimicrobial therapy.
    Polen CB; Judd WR; Ratliff PD; King GS
    Am J Infect Control; 2018 May; 46(5):538-541. PubMed ID: 29305281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Early De-escalation of Antimicrobial Therapy on Risk of Clostridioides difficile Infection Following Enterobacteriaceae Bloodstream Infections.
    Seddon MM; Bookstaver PB; Justo JA; Kohn J; Rac H; Haggard E; Mediwala KN; Dash S; Al-Hasan MN
    Clin Infect Dis; 2019 Jul; 69(3):414-420. PubMed ID: 30312362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Host factors are more important in predicting recurrent Clostridium difficile infection than ribotype and use of antibiotics.
    van Beurden YH; Nezami S; Mulder CJJ; Vandenbroucke-Grauls CMJE
    Clin Microbiol Infect; 2018 Jan; 24(1):85.e1-85.e4. PubMed ID: 28782647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic Inflammatory Responses in Ulcerative Colitis Patients and Clostridium difficile Infection.
    Limsrivilai J; Rao K; Stidham RW; Govani SM; Waljee AK; Reinink A; Johnson L; Briggs E; Higgins PDR
    Dig Dis Sci; 2018 Jul; 63(7):1801-1810. PubMed ID: 29644517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of Clostridium difficile infection in hospitalized patients receiving metronidazole for a non-C difficile infection.
    Rodriguez S; Hernandez MB; Tarchini G; Zaleski M; Vatanchi M; Cardona L; Castro-Pavia F; Schneider A
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1856-61. PubMed ID: 24681079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Community-onset Clostridium difficile infection at a tertiary medical center in southern Taiwan, 2007-2015.
    Tsai CS; Hung YP; Lee JC; Lee NY; Chen PL; Syue LS; Li MC; Li CW; Ko WC
    J Microbiol Immunol Infect; 2018 Apr; 51(2):243-250. PubMed ID: 28089100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Comprehensive Study of Costs Associated With Recurrent Clostridium difficile Infection.
    Rodrigues R; Barber GE; Ananthakrishnan AN
    Infect Control Hosp Epidemiol; 2017 Feb; 38(2):196-202. PubMed ID: 27817758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences of the Fecal Microflora With Clostridium difficile Therapies.
    Louie TJ; Byrne B; Emery J; Ward L; Krulicki W; Nguyen D; Wu K; Cannon K
    Clin Infect Dis; 2015 May; 60 Suppl 2():S91-7. PubMed ID: 25922407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The burden of Clostridium difficile in surgical patients in the United States.
    Zerey M; Paton BL; Lincourt AE; Gersin KS; Kercher KW; Heniford BT
    Surg Infect (Larchmt); 2007 Dec; 8(6):557-66. PubMed ID: 18171114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacologic Approach to Management of Clostridium difficile Infection.
    Martin LT; Vincent S; Gillian S; Moore K; Ratermann D; Droege CA
    Crit Care Nurs Q; 2019; 42(1):2-11. PubMed ID: 30507659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proton Pump Inhibitors Do Not Increase Risk for Clostridium difficile Infection in the Intensive Care Unit.
    Faleck DM; Salmasian H; Furuya EY; Larson EL; Abrams JA; Freedberg DE
    Am J Gastroenterol; 2016 Nov; 111(11):1641-1648. PubMed ID: 27575714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.